An interview with Dr Stephen Bright on why Australia needs to mount a clinical trial of MDMA-assisted therapy sooner rather than later.
Share this post
Innovative psychedelic research
The re-emergence of psychedelic research places a crucial emphasis on a holistic approach to mental health from pharmacology, neurobiological process, ecological connection, and therapeutic support. PRISM supports research and clinical development of therapies where current options provide limited relief.
Your support allows us to pursue cutting edge research for next-generation mental health care.